[1]
2024. Prognostic Significance of TP53 Alterations in Patients with Therapy-Related Myeloid Neoplasms. Annals of Leukemia Research. 5, 1 (Nov. 2024), 31–36. DOI:https://doi.org/10.5281/zenodo.22227599.